The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Cited by (1,044)

Items 501–600 of 1,044

1. The selection and use of essential medicines.
   Peter N. Kazembe, Jehan Al Fannah, Kalle Hoppu, Elizabeta Zisovska, HB Pedersen, S Hill, Clive O. Ondari, Dianne Janette Terlouw, Donald R. Mattison, LI Zhi-ping et al. · 2004 · PubMed
2. Heart Failure in Frail Elderly Patients: Diagnostic Difficulties, Co-Morbidities, Polypharmacy and Treatment Dilemmas
   Christopher T.C. Lien, Neil D. Gillespie, Allan D. Struthers, Marion E. T. McMurdo · 2002 · European Journal of Heart Failure
3. Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease
   Marcello A. Tonelli, S. Ananth Karumanchi, Ravi Thadhani · 2016 · Circulation
4. Fontan-Associated Liver Disease
   Curt J. Daniels, Elisa A. Bradley, Mike Landzberg, Jamil Aboulhosn, Robert H. Beekman, Wendy Book, Michelle Z. Gurvitz, Anitha S. John, Binu V. John, Ariane J. Marelli et al. · 2017 · Journal of the American College of Cardiology
5. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
   Mariell L Jessup, William T. Abraham, Donald E. Casey, Arthur Michael Feldman, Gary S. Francis, Théodore G. Ganiats, Marvin A. Konstam, DONNA M. MANCINI, Peter S. Rahko, Marc A. Silver et al. · 2009 · Journal of the American College of Cardiology
6. Effects of Long-Term Monotherapy With Eplerenone, a Novel Aldosterone Blocker, on Progression of Left Ventricular Dysfunction and Remodeling in Dogs With Heart Failure
   George Suzuki, Hideaki Morita, Takayuki Mishima, Victor G. Sharov, Anastassia V. Todor, Elaine J. Tanhehco, Amy E. Rudolph, Ellen Garwitz McMahon, Sidney Goldstein, Hani N. Sabbah · 2002 · Circulation
7. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function
   M. Bay, V Kirk, J Parner, C Hassager, H Nielsen, Kim Krogsgaard, J Trawinski, S Boesgaard, J Aldershvile · 2003 · Heart
8. How to develop cost-conscious guidelines
   Martin Eccles, James M. Mason · 2001 · Health Technology Assessment
9. Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
   Luis Miguel Ruilope, Rajiv Agarwal, Stefan D. Anker, George L. Bakris, Gerasimos Filippatos, Christina Nowack, Peter Kolkhof, Amer Joseph, Nicole Mentenich, Bertram Pitt et al. · 2019 · American Journal of Nephrology
10. Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research
    Freemantle, N., Marston, L., Walters, K., Wood, J., Reynolds, M. R., Petersen, I. · 2013 · BMJ
11. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
    Nilsson, Erik, Gasparini, Alessandro, Ärnlöv, Johan, Xu, Hairong, Henriksson, Karin M., Coresh, Josef, Grams, Morgan E., Carrero, Juan Jesus · 2017 · International Journal of Cardiology
12. Aldosterone Induces Angiotensin-Converting-Enzyme Gene Expression in Cultured Neonatal Rat Cardiocytes
    Eisaku Harada, Michihiro Yoshimura, Hirofumi Yasue, Osamu Nakagawa, Masayo Nakagawa, Masaki Harada, Yuji Mizuno, Masafumi Nakayama, Yukio Shimasaki, Teruhiko Ito et al. · 2001 · Circulation
13. Renal sodium avidity in heart failure: from pathophysiology to treatment strategies
    Wilfried Müllens, Frederik Hendrik Verbrugge, Petra Nijst, W.H. Wilson Tang · 2017 · European Heart Journal
14. Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-κB Activation in Angiotensin II–Induced Cardiac Injury
    Anette Fiebeler, Folke H. Schmidt, Dominik N. Müller, Joon-Keun Park, Ralf Dechend, Markus Bieringer, Erdenechimeg Shagdarsuren, Volker Breu, Hermann G. Haller, Friedrich Cameron Luft · 2001 · Hypertension
15. Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen
    Ilan E. Raymond, F Pedersen, F Steensgaard-Hansen, A Green, Michael Busch-Sørensen, C Tuxen, J Appel, J Jacobsen, D Atar, P Hildebrandt · 2003 · Heart
16. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials
    Máximo Rivero‐Ayerza, Dominic A.M.J. Theuns, Héctor M. García‐García, Eric H. Boersma, Maarten L. Simoons, Luc J.L.M. Jordaens · 2006 · European Heart Journal
17. Cirrhotic cardiomyopathy
    Florence Suet-Hing Wong · 2008 · Hepatology International
18. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease
    Humberto Felı́cio Gonçalves de Freitas, Paulo Roberto Chizzola, Ângela Tavares Paes, Antonio C.P. Lima, Alfredo José Mansur · 2004 · International Journal of Cardiology
19. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic rats
    Goran Miric, Catherine Dallemagne, Zoltan Huba Endre, Solomon B. Margolin, Stephen M. Taylor, Lindsay Brown · 2001 · British Journal of Pharmacology
20. Hyperparathyroidism and the Calcium Paradox of Aldosteronism
    Vikram S. Chhokar, Yao Sun, Syamal K. Bhattacharya, Robert A. Ahokas, Linda K. Myers, Zhiqing Xing, Richard Anthony Smith, Ivan Gerling, Karl T. Weber · 2005 · Circulation
21. Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist
    Orly Vardeny, Brian Lee Claggett, Inder S. Anand, Patrick Rossignol, Akshay Suvas Desai, Faiez M. Zannad, Bertram Pitt, Scott David Solomon · 2014 · Circulation Heart Failure
22. Pathophysiological effects of aldosterone in cardiovascular tissues
    Ricardo Rocha, Charles T. Stier · 2001 · Trends in Endocrinology and Metabolism
23. The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure
    McKelvie, Robert S., Moe, Gordon W., Ezekowitz, Justin A., Heckman, George A., Costigan, Jeannine, Ducharme, Anique, Estrella-Holder, Estrellita, Giannetti, Nadia, Grzeslo, Adam, Harkness, Karen et al. · 2013 · Canadian Journal of Cardiology
24. Link between the renin–angiotensin system and insulin resistance: Implications for cardiovascular disease
    Ming-Sheng Zhou, Ivonne Hernandez Schulman, Qiang Zeng · 2012 · Vascular Medicine
25. State of the Art: Clinical Applications of Cardiac T1 Mapping
    Erik B. Schelbert, Daniel Messroghli · 2016 · Radiology
26. Effect of Cardiac Resynchronization on Myocardial Efficiency and Regional Oxidative Metabolism
    Heikki Ukkonen, Rob S. Beanlands, Ian G. Burwash, Rob de Kemp, Claude Nahmias, Ernest L. Fallen, Michael R.S. Hill, Anthony Tang · 2003 · Circulation
27. The Renin-Angiotensin-Aldosterone System and Heart Failure
    GABRIEL T. SAYER, Geetha Bhat · 2013 · Cardiology Clinics
28. Blood Urea Nitrogen and Serum Creatinine
    Robert W. Schrier · 2008 · Circulation Heart Failure
29. Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology
    John A. Delyani · 2000 · Kidney International
30. Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy
    Lynne Warner Stevenson, Leslie W. Miller, Patrice M. Desvigne-Nickens, Deborah Davis Ascheim, Michael K. Parides, Dale G. Renlund, Ronald M. Oren, Steven K. Krueger, Maria Rosa Costanzo, L. Samüel Wann et al. · 2004 · Circulation
31. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction
    Paul Milliez, Noeleen DeAngelis, Catherine Rücker‐Martin, Antoine Leenhardt, Éric Vicaut, Estelle Robidel, Philippe Beaufils, Claude Delcayre, Stéphane N. Hatem · 2005 · European Heart Journal
32. Aldosterone Synthase Inhibition With LCI699
    Laurence Amar, Michel Azizi, Joël Ménard, Séverine Peyrard, Catherine E. Watson, Pierre‐François Plouin · 2010 · Hypertension
33. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
    Giuseppe M.C. Rosano, Juan Luis Tamargo, Keld P. Kjeldsen, Mitja Lainščak, Stefan Agewall, Stefan D. Anker, Claudio Ceconi, Andrew J.S. Coats, Heinz Drexel, Gerasimos S Filippatos et al. · 2018 · European Heart Journal - Cardiovascular Pharmacotherapy
34. Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction
    Miranda E. Merrill, Nancy K. Sweitzer, JoAnn Lindenfeld, David Peter Kao · 2019 · JACC Heart Failure
35. Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
    Kieran F. Docherty, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr P. Ponikowski, David L. DeMets, Marc Steven Sabatine, Olof Bengtsson et al. · 2020 · European Heart Journal
36. Peripartum cardiomyopathy
    Michael C. Honigberg, Michael M. Givertz · 2019 · BMJ
37. The role of spironolactone in the treatment of patients with refractory hypertension
    James M. Ouzan, Catherine Perault, Abraham Michael Lincoff, E. Carre, Paul‐Michel Mertès · 2002 · American Journal of Hypertension
38. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure
    Michel F. Rousseau, Olivier Gurné, Daniel A. Duprez, W. Van Mieghem, Annie R Robert, Sylvie A. Ahn, Laurence M Galanti, Jean-Marie Ketelslegers · 2002 · Journal of the American College of Cardiology
39. Beneficial effects of potassium
    He, Feng J, MacGregor, Graham A · 2001 · BMJ
40. 2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension
    Chern‐En Chiang, Tzung‐Dau Wang, Kwo-Chang Ueng, Tsung‐Hsien Lin, Hung‐I Yeh, Chung-Yin Chen, Yih-Jer Wu, Wei‐Chuan Tsai, Ting‐Hsing Chao, Chen-Huan Chen et al. · 2014 · Journal of the Chinese Medical Association
41. Impaired Endothelium-Dependent Flow-Mediated Vasodilation in Hypertensive Subjects With Hyperaldosteronism
    Mari Nishizaka, Mohammad A. Zaman, Sharon A. Green, Kerry Y. Renfroe, David A. Calhoun · 2004 · Circulation
42. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study
    Tiew‐Hwa Katherine Teng, Jasper Tromp, Wan Ting Tay, Inder S. Anand, Wouter Ouwerkerk, Vijay Chopra, Gurpreet Singh Wander, Jonathan JL Yap, Michael Ross MacDonald, Chang Fen Xu et al. · 2018 · The Lancet Global Health
43. Successful Long-Term Treatment of Refractory Cushing's Disease with High-Dose Mifepristone (RU 486)
    James W. Chu, Dwight Matthias, Joseph K. Belanoff, Alan F. Schatzberg, Andrew R. Hoffman, David Feldman · 2001 · The Journal of Clinical Endocrinology & Metabolism
44. Fighting Against Age Discrimination in Clinical Trials
    Antonio Cherubini, Susanna Del Signore, Joe Ouslander, Todd P. Semla, Jean‐Pierre Michel · 2010 · Journal of the American Geriatrics Society
45. Kidney-Heart Interactions
    Tomás Berl, William L. Henrich · 2005 · Clinical Journal of the American Society of Nephrology
46. POOR NUTRITIONAL STATUS AND INFLAMMATION: Metabolic Acidosis and Malnutrition‐Inflammation Complex Syndrome in Chronic Renal Failure
    Kamyar Kalantar‐Zadeh, Rajnish Mehrotra, Denis P. Fouque, Joel D. Kopple · 2004 · Seminars in Dialysis
47. Associations of serum potassium levels with mortality in chronic heart failure patients
    Mette Aldahl, Anne-Sofie Caroline Jensen, Line Davidsen, Matilde Alida Eriksen, Steen Møller Hansen, Berit Jamie Nielsen, Maria Lukács Krogager, Lars Køber, Christian Tobias Torp-Pedersen, Peter Søgaard · 2017 · European Heart Journal
48. Heart Failure in Women
    Eileen Hsich, Ileana L. Piña · 2009 · Journal of the American College of Cardiology
49. Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1
    Larbi Amazit, Florian Le Billan, Peter Kolkhof, Khadija Lamribet, Say Viengchareun, Michel Fay, Junaid Ali Khan, Alexander Hillisch, Marc Lombès, M.E. Rafestin-Oblin et al. · 2015 · Journal of Biological Chemistry
50. Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure Patients
    Shlomo Keidar, Aviva Gamliel-Lazarovich, Marielle Kaplan, Elsa Pavlotzky, Shadi Hamoud, Tony Hayek, Rachel Karry, Zaid A. Abassi · 2005 · Circulation Research
51. Temporal Trends and Patterns in Mortality After Incident Heart Failure
    Nathalie Conrad, Andrew Judge, Dexter Canoy, Jenny Tran, Ana‐Catarina Pinho‐Gomes, Elizabeth R. C. Millett, Gholamreza Salimi‐Khorshidi, John G.F. Cleland, John J.V. McMurray, Kazem Rahimi · 2019 · JAMA Cardiology
52. Combined Blockade of the Renin-Angiotensin System With Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists
    Michel Azizi, Joël Ménard · 2004 · Circulation
53. Normal Reference Intervals for Cardiac Dimensions and Function for Use in Echocardiographic Practice: A Guideline from the British Society of Echocardiography
    Allan Harkness, Liam S. Ring, Daniel Xavier Augustine, David Oxborough, Shaun Robinson, Vishal Sharma · 2020 · Echo Research and Practice
54. Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
    Mark Sweeney, Ben Corden, Stuart A. Cook · 2020 · EMBO Molecular Medicine
55. Mineralocorticoid Receptor Inhibition Ameliorates the Transition to Myocardial Failure and Decreases Oxidative Stress and Inflammation in Mice With Chronic Pressure Overload
    Gabriela M. Kuster, Eugene Kotlyar, Mary Katherine Rude, Deborah A. Siwik, Ronglih Liao, Wilson S. Colucci, Flora Sam · 2005 · Circulation
56. Contemporary Use of Digoxin in the Management of Cardiovascular Disorders
    Mihai Gheorghiade, Dirk Jan van Veldhuisen, Wilson S. Colucci · 2006 · Circulation
57. Incidence, Predictors and Clinical Management of Hyperkalaemia in New Users of Mineralocorticoid Receptor Antagonists
    Marco Trevisan, Pietro de Deco, Hairong Xu, Marie Evans, Bengt Lindholm, Rino Bellocco, Peter F. Barany, Tomas Jernberg, Lars H. Lund, Juan Jesús Carrero · 2018 · European Journal of Heart Failure
58. Cardiac fibrosis: potential therapeutic targets
    Shuin Park, Ngoc B. Nguyen, Arash Pezhouman, Reza Ardehali · 2019 · Translational research
59. Sex- and Gender-Based Pharmacological Response to Drugs
    Franck Mauvais‐Jarvis, Heiner K. Berthold, Ilaria Campesi, Juan Jesús Carrero, Santosh Dhakal, Flavia Franconi, Ioanna Gouni‐Berthold, Mark L. Heiman, Alexandra Kautzky‐Willer, Sabra L. Klein et al. · 2021 · Pharmacological Reviews
60. Diuretics for heart failure
    Rajaa F Faris, Marcus D Flather, Henry Purcell, Philip Alexander Poole-Wilson, Andrew J.S. Coats · 2016 · Cochrane Database of Systematic Reviews · Retracted
61. The Sympathetic Nervous System and Heart Failure
    David Y. Zhang, Allen S. Anderson · 2013 · Cardiology Clinics
62. The Cooperative Roles of Inflammation and Oxidative Stress in the Pathogenesis of Hypertension
    Steven D. Crowley · 2013 · Antioxidants and Redox Signaling
63. Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure
    Mariantonietta Cicoira, Luisa Zanolla, Andrea Rossi, Giorgio Golia, Lorenzo Franceschini, Giovanna Brighetti, Paolo Nicola Marino, Piero Zardini · 2002 · Journal of the American College of Cardiology
64. Triiodothyronine levels for risk stratification of patients with chronic heart failure
    Pingitore, Alessandro, Landi, Patrizia, Taddei, Maria Chiara, Ripoli, Andrea, L’Abbate, Antonio, Iervasi, Giorgio · 2005 · The American Journal of Medicine
65. Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure
    Inder S. Anand, Peter E. Carson, Elizabeth G. Galle, Rui Song, JOHN P. BOEHMER, Jalal K. Ghali, Brian E. Jaski, JoAnn M. Lindenfeld, Christopher M. O’Connor, Jonathan S. Steinberg et al. · 2009 · Circulation
66. A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule
    Jérôme Fagart, Alexander Hillisch, Jessica Huyet, Lars Bärfacker, Michel Fay, U. Pleiß, Elisabeth Pook, Stefan Schäfer, M.E. Rafestin-Oblin, Peter Kolkhof · 2010 · Journal of Biological Chemistry
67. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure
    Mattie J. Lenzen, Eric H. Boersma, Wilma J.M. Scholte op Reimer, Aggie H.M.M. Balk, Michel Komajda N, Karl B Swedberg, Ferenc Folláth, Manuel Francisco Jiménez-Navarro, Maarten L. Simoons, John G.F. Cleland · 2005 · European Heart Journal
68. Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium Homeostasis
    Domenic A. Sica · 2005 · Heart Failure Reviews
69. Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene
    Wei Wu, Antoine Muchir, Jian Shan, Gisèle Bonne, Howard J. Worman · 2010 · Circulation
70. Diagnosis and management of dilated cardiomyopathy
    Perry M Elliot · 2000 · Heart
71. Brugada syndrome: 1992–2002
    Charles N Antzelevitch, Pedro Brugada, Josép Brugada, Ramón Brugada, Jeffrey Allen Towbin, Kolawanee Nademanee · 2003 · Journal of the American College of Cardiology
72. Summary of Recommendations
    Silvia Giuliana Priori · 2002 · EP Europace
73. Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure
    Prins, Kurt W., Neill, John M., Tyler, John O., Eckman, Peter M., Duval, Sue · 2015 · JACC: Heart Failure
74. Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone
    Mitja Lainščak, Francesco Pelliccia, Giuseppe Massimo Claudio Rosano, Cristiana Vitale, Michele Salvatore Schiariti, Cesare Greco, Giuseppe Speziale, Carlo Gaudio · 2015 · International Journal of Cardiology
75. The evolution of aldosterone antagonists
    Susan M. Garthwaite, Ellen Garwitz McMahon · 2004 · Molecular and Cellular Endocrinology
76. Characterization of Structure and Function of ZS-9, a K+ Selective Ion Trap
    Fiona D. Stavros, Alex Yang, Alejandro Leon, Mark Nuttall, Henrik Sandvad Rasmussen · 2014 · PLoS ONE
77. JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
    Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, Yasuki Kihara, Koichiro Kinugawa, Shintaro Kinugawa, Miyuki Makaya, Toyoaki Murohara, Koichi Node, Yoshihiko Saito et al. · 2021 · Circulation Journal
78. The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
    Milton Packer · 2025 · Journal of the American College of Cardiology
79. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population
    Bjoern Aaris Groenning, Ilan E. Raymond, Per Rossen Hildebrandt, Jens Christian Nilsson, M Baumann, Frants Pedersen · 2004 · Heart
80. Cardiovascular effects of relaxin: from basic science to clinical therapy
    Du, Xiao-Jun, Bathgate, Ross A. D., Samuel, Chrishan S., Dart, Anthony M., Summers, Roger J. · 2010 · Nature Reviews Cardiology
81. High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction
    Farzin Beygui, Jean‐Philippe Collet, J.J. Benoliel, Nicolas Vignolles, Raphaelle L. Dumaine, Olivier Barthélémy, Gilles Montalescot · 2006 · Circulation
82. SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects
    Carolyn S.P. Lam, Chanchal Chandramouli, Vineeta Ahooja, Subodh Verma · 2019 · Journal of the American Heart Association
83. Challenges, solutions and future directions in the evaluation of service innovations in health care and public health
    Rosalind Raine, Ray M. Fitzpatrick, Helen Barratt, Gywn Bevan, Nick A. Black, Ruth Boaden, Peter Bower, Marion Campbell, Jean‐Louis Denis, Kelly J. Devers et al. · 2016 · Health Services and Delivery Research
84. A review of the medical treatment of primary aldosteronism
    Pitt O. Lim, William F. Young, Thomas MacLennan MacDonald · 2001 · Journal of Hypertension
85. Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling
    James D. Stockand, J. Gary Meszaros · 2003 · American Journal of Physiology-Heart and Circulatory Physiology
86. Molecular Mechanism of the Inhibitory Effect of Aldosterone on Endothelial NO Synthase Activity
    Daisuke Nagata, Masao Takahashi, Kuniko Sawai, Tetsuya Tagami, Takeshi Usui, Akira Shimatsu, Yasunobu Hirata, Mitsuhide Naruse · 2006 · Hypertension
87. Cardiovascular drug therapy in the elderly: benefits and challenges
    Fleg, Jerome L., Aronow, Wilbert S., Frishman, William H. · 2011 · Nature Reviews Cardiology
88. Primary aldosteronism—careful investigation is essential and rewarding
    Michael Stowasser, Richard D. Gordon · 2003 · Molecular and Cellular Endocrinology
89. Heart Failure in the 21st Century: A Cardiogeriatric Syndrome
    Michael W. Rich · 2001 · The Journals of Gerontology Series A
90. Synergistic Effect of Adrenal Steroids and Angiotensin II on Plasminogen Activator Inhibitor-1 Production
    Nancy Jeanne Brown, Kyung‐Soo Kim, Yan Chen, Lewis S. Blevins, John Nadeau, Steven G. Meranze, Douglas E. Vaughan · 2000 · The Journal of Clinical Endocrinology & Metabolism
91. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure
    Ali Ahmed, Faiez M. Zannad, Thomas E. Love, Jose Antonio Tallaj, Mihai Gheorghiade, O. James Ekundayo, Bertram Pitt · 2007 · European Heart Journal
92. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)
    Smith, Sidney C., Jr. · 2019 · PubMed
93. Heart Failure Care in the Outpatient Cardiology Practice Setting
    Gregg C. Fonarow, Clyde W. Yancy, Nancy M. Albert, Anne B. Curtis, Wendy Gattis Stough, Mihai Gheorghiade, James Thomas Heywood, Mark L. McBride, Mandeep R. Mehra, Christopher M. O’Connor et al. · 2008 · Circulation Heart Failure
94. The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
    Pieter Martens, Hanne Beliën, Matthias Dupont, Pieter M. Vandervoort, Wilfried Müllens · 2018 · Cardiovascular Therapeutics
95. Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
    Bakris, George L., Agarwal, Rajiv, Anker, Stefan D., Pitt, Bertram, Ruilope, Luis M., Nowack, Christina, Kolkhof, Peter, Ferreira, Anna C., Schloemer, Patrick, Filippatos, Gerasimos et al. · 2019 · American Journal of Nephrology
96. Heart Failure With Recovered Ejection Fraction: A Distinct Clinical Entity
    Lynn Punnoose, Michael M. Givertz, Eldrin Foster Lewis, Parakash P. Pratibhu, Lynne Warner Stevenson, Akshay Suvas Desai · 2011 · Journal of Cardiac Failure
97. Sudden cardiac death: epidemiology, pathogenesis and management
    Akshay Kumar, Dor Mordehay Avishay, Calvin Richard Jones, Juber Dastagir Shaikh, Roopvir Kaur, Michael M. Aljadah, Asim Kichloo, Nimisha Shiwalkar, Suresh Keshavamurthy · 2021 · Reviews in Cardiovascular Medicine
98. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: Executive Summary
    Jeffrey L. Anderson, Cynthia D. Adams, Elliott Marshall Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin et al. · 2007 · Circulation
99. Baseline Characteristics of Patients in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial
    Sanjiv Jayendra Shah, John F. Heitner, Nancy K. Sweitzer, Inder S. Anand, Hae-Young Kim, Brian J. Harty, Robin Boineau, Nadine Clausell, Akshay Suvas Desai, Rafael Díaz et al. · 2012 · Circulation Heart Failure
100. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
     Giuseppe Boriani, Irina Savelieva, Gheorghe‐Andrei Dan, Jean‐Claude Deharo, Charles Joseph Ferro, Carsten Walter Israel, Deirdre A. Lane, Gaetano La Manna, Joseph B. Morton, Àngel Moya‐Mitjans et al. · 2015 · EP Europace